Core Insights - The company is experiencing a phase of recovery in the infant formula market, although the overall birth rate remains under pressure in the coming years [1][2] - The company plans to strengthen its core infant formula business, accelerate new product launches, and implement refined channel operations to explore new market growth opportunities [1][2] Company Strategy - The company has identified three core strategies: focus on core business and advantages, agility in responding to consumer needs, and enhancing team cohesion to tackle market challenges [1] - The company has achieved double-digit revenue growth for four consecutive years, indicating the effectiveness of its strategies [1] Market Performance - In 2024, the company's revenue from its professional nutrition business in China is projected to reach €1.218 billion, with operating profit increasing to €227 million [2] - The company's brand, Friso, has shown strong growth in the Chinese market, contributing significantly to overall revenue [2] Market Trends - The overall sales of infant formula are expected to decline by 5.9% in 2024, but the decline has narrowed to 0.8% in the first quarter of this year [2] - The high-end segment of the infant formula market is growing faster than the mid-range segment, with consumers increasingly prioritizing quality and experience [2] Investment in China - China is a crucial market for the company, and it plans to increase investments in the region while enhancing local market responsiveness [3] - The company is considering moving product testing to China to improve the efficiency of new product launches [3]